Skip to main content

Boundless Bio Inc

For the period ended Mar 31, 2024. Filed May 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

BOLD$2.460.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

Exhibit · Incorporated by Reference · Filed
NumberDescriptionFormDateNumberHerewith
3.1Amended and Restated Certificate of Incorporation8-K4/2/243.1
3.2Amended and Restated Bylaws8-K4/2/243.2
4.1Specimen stock certificate evidencing the shares of common stockS-1/A3/21/244.1
4.2Amended and Restated Investor Rights Agreement, dated April 5, 2023, by and among the Registrant and certain of its stockholdersS-13/6/244.2
10.1#Boundless Bio, Inc. 2018 Equity Incentive Plan, as amended, and form of stock option agreement and form of restricted stock agreement thereunderS-13/6/2410.1
10.2#Boundless Bio, Inc. 2024 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunderS-1/A3/21/2410.2
10.3#Boundless Bio, Inc. 2024 Employee Stock Purchase PlanS-1/A3/21/2410.3
10.4#Non-Employee Director Compensation ProgramS-1/A3/21/2410.4
10.5#Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Zachary D. Hornby and the RegistrantS-13/6/2410.6
10.6#Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Jami Rubin and the RegistrantS-13/6/2410.8
10.7#Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Klaus Wagner, M.D, Ph.D. and the RegistrantS-13/6/2410.10
10.8#Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Christian Hassig, Ph.D. and the RegistrantS-13/6/2410.12
10.9#Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Neil Abdollahian and the RegistrantS-13/6/2410.14
10.10#Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Jessica Oien and the RegistrantS-13/6/2410.16
10.11#Severance and Change in Control Severance PlanS-13/6/2410.17
10.12#Corporate Bonus PlanS-13/6/2410.18
10.13#Form of Indemnification Agreement for Directors and OfficersS-1/A3/21/2410.19
10.14#Policy for the Recovery of Erroneously Awarded CompensationS-13/6/2410.20
31.1Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
31.2Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
32.1*Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.X
101.SCHInline XBRL Taxonomy Extension Schema With Embedded Linkbase DocumentsX
104Cover Page Interactive Data File (embedded within the Inline XBRL document)X
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.